Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

VVUS

VIVUS (VVUS)

VIVUS Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VVUS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
08/28/2019	7:30AM	GlobeNewswire Inc.	VIVUS to Present at Upcoming Conferences	NASDAQ:VVUS	VIVUS Inc
08/27/2019	7:37AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
08/27/2019	7:30AM	GlobeNewswire Inc.	VIVUS to Share Qsymia® Safety and Efficacy Data with a Global Audience at ICOMES & AOCO 2019	NASDAQ:VVUS	VIVUS Inc
08/20/2019	7:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
08/20/2019	7:30AM	GlobeNewswire Inc.	New Pilot Clinical Study Results Demonstrate that Addition of VIVUS’ Qsymia® to Gastric Sleeve Surgery Significantly Impro...	NASDAQ:VVUS	VIVUS Inc
08/09/2019	4:06PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
08/06/2019	4:53PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VVUS	VIVUS Inc
08/06/2019	4:12PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
08/06/2019	4:05PM	GlobeNewswire Inc.	VIVUS Reports Second Quarter 2019 Financial Results	NASDAQ:VVUS	VIVUS Inc
08/06/2019	4:03PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VVUS	VIVUS Inc
08/05/2019	7:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
08/05/2019	7:30AM	GlobeNewswire Inc.	VIVUS Announces Approval of Qsymia® in the Republic of Korea	NASDAQ:VVUS	VIVUS Inc
07/23/2019	7:30AM	GlobeNewswire Inc.	VIVUS to Host Second Quarter Business Update and Financial Results Conference Call on Tuesday, August 6, 2019	NASDAQ:VVUS	VIVUS Inc
06/26/2019	4:12PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
06/26/2019	4:05PM	GlobeNewswire Inc.	VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE®	NASDAQ:VVUS	VIVUS Inc
06/11/2019	7:33AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
06/11/2019	7:30AM	GlobeNewswire Inc.	VIVUS Reduces Barrier to Achieving Healthy Weight Goals With Launch of Online Platform to Purchase Qsymia®	NASDAQ:VVUS	VIVUS Inc
06/07/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
05/28/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
05/28/2019	7:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
05/28/2019	7:30AM	GlobeNewswire Inc.	VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents	NASDAQ:VVUS	VIVUS Inc
05/15/2019	5:26PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VVUS	VIVUS Inc
05/15/2019	5:18PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VVUS	VIVUS Inc
05/15/2019	7:53AM	GlobeNewswire Inc.	VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance	NASDAQ:VVUS	VIVUS Inc
05/15/2019	7:36AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
05/03/2019	4:09PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
04/30/2019	4:29PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
04/30/2019	4:20PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VVUS	VIVUS Inc
04/30/2019	4:06PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VVUS	VIVUS Inc
04/30/2019	4:05PM	GlobeNewswire Inc.	VIVUS Reports First Quarter 2019 Financial Results	NASDAQ:VVUS	VIVUS Inc